Also, at the molecular level, Zhang et al. [42] have demonstrated that in the tumor xenograft experiment, ropivacaine was confirmed to inhibit tumor growth, accompanied by inhibition of the IGF-1 R/PI3K/AKT/mTOR signaling axis. Here, MTOR is linked to neoplasm.